Literature DB >> 27206666

Dissecting stroke for anti-VWF therapeutics.

Jing-Fei Dong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27206666      PMCID： PMC4865587          DOI： 10.1182/blood-2016-03-704304

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network.

Authors:  Adam Miszta; Leonie Pelkmans; Theo Lindhout; Ganeshram Krishnamoorthy; Philip G de Groot; Coenraad H Hemker; Johan W M Heemskerk; Hilde Kelchtermans; Bas de Laat
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

2.  ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.

Authors:  Frederik Denorme; Friederike Langhauser; Linda Desender; Aline Vandenbulcke; Hanspeter Rottensteiner; Barbara Plaimauer; Olivier François; Tommy Andersson; Hans Deckmyn; Friedrich Scheiflinger; Christoph Kleinschnitz; Karen Vanhoorelbeke; Simon F De Meyer
Journal:  Blood       Date:  2016-02-29       Impact factor: 22.113

3.  Low ADAMTS13 activity is associated with an increased risk of ischemic stroke.

Authors:  Michelle A H Sonneveld; Moniek P M de Maat; Marileen L P Portegies; Maryam Kavousi; Albert Hofman; Peter L Turecek; Hanspeter Rottensteiner; Fritz Scheiflinger; Peter J Koudstaal; M Arfan Ikram; Frank W G Leebeek
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

4.  Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.

Authors:  Claudia Tersteeg; Steven de Maat; Simon F De Meyer; Michel W J Smeets; Arjan D Barendrecht; Mark Roest; Gerard Pasterkamp; Rob Fijnheer; Karen Vanhoorelbeke; Philip G de Groot; Coen Maas
Journal:  Circulation       Date:  2014-01-21       Impact factor: 29.690

5.  Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy.

Authors:  Antonia Sambola; Bruno García Del Blanco; Marisol Ruiz-Meana; Jaume Francisco; José A Barrabés; Jaume Figueras; Jordi Bañeras; Imanol Otaegui; Angeles Rojas; Úrsula Vilardosa; Joan Montaner; David García-Dorado
Journal:  Thromb Haemost       Date:  2016-03-10       Impact factor: 5.249

6.  Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.

Authors:  Rohit Bhatia; Michael D Hill; Nandavar Shobha; Bijoy Menon; Simerpreet Bal; Puneet Kochar; Tim Watson; Mayank Goyal; Andrew M Demchuk
Journal:  Stroke       Date:  2010-09-09       Impact factor: 7.914

7.  ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

Authors:  Masayuki Fujioka; Kazuhide Hayakawa; Kenichi Mishima; Ai Kunizawa; Keiichi Irie; Sei Higuchi; Takafumi Nakano; Carl Muroi; Hidetada Fukushima; Mitsuhiko Sugimoto; Fumiaki Banno; Koichi Kokame; Toshiyuki Miyata; Michihiro Fujiwara; Kazuo Okuchi; Kenji Nishio
Journal:  Blood       Date:  2009-11-13       Impact factor: 22.113

8.  Deficiency of von Willebrand factor protects mice from ischemic stroke.

Authors:  Christoph Kleinschnitz; Simon F De Meyer; Tobias Schwarz; Madeleine Austinat; Karen Vanhoorelbeke; Bernhard Nieswandt; Hans Deckmyn; Guido Stoll
Journal:  Blood       Date:  2009-01-30       Impact factor: 22.113

9.  von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

Authors:  Bing-Qiao Zhao; Anil K Chauhan; Matthias Canault; Ian S Patten; Janie J Yang; Michael Dockal; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113

10.  Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke.

Authors:  Michael K Schuhmann; Ignaz Gunreben; Christoph Kleinschnitz; Peter Kraft
Journal:  Int J Mol Sci       Date:  2016-02-26       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.